Provided by Tiger Trade Technology Pte. Ltd.

Xenetic Biosciences Inc

2.08
-0.0100-0.48%
Volume:1.96K
Turnover:4.08K
Market Cap:4.77M
PE:-1.02
High:2.11
Open:2.11
Low:2.07
Close:2.09
52wk High:13.93
52wk Low:1.90
Shares:2.29M
Float Shares:1.92M
Volume Ratio:0.61
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0467
EPS(LYR):-2.5694
ROE:-57.43%
ROA:-31.56%
PB:1.21
PE(LYR):-0.81

Loading ...

Xenetic Biosciences Extends Research Collaboration with Scripps Research to Advance DNase Platform

Reuters
·
Nov 19, 2025

Xenetic Biosciences Reports Higher Q3 Revenue and Closes $3.9 Million Offering

Reuters
·
Nov 13, 2025

Xenetic Biosciences Q3 Net Income USD -500 Thousand

THOMSON REUTERS
·
Nov 13, 2025

Xenetic Biosciences Announces $4.5 Million Underwritten Offering of Common Stock at $6.12 Per Share

Reuters
·
Oct 14, 2025

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges

Benzinga
·
Oct 11, 2025

Xenetic Biosciences trading resumes

TIPRANKS
·
Oct 10, 2025

Xenetic 735,000 share Spot Secondary priced at $6.12

TIPRANKS
·
Oct 10, 2025

Xenetic Biosciences Announces 45 Million Underwritten Offering of Common Stock

Reuters
·
Oct 10, 2025

Xenetic Biosciences Inc Files for Offering to Sell Shares of Common Stock- SEC Filing

THOMSON REUTERS
·
Oct 10, 2025

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings

Benzinga_recent_news
·
Oct 09, 2025

Nasdaq Gains 150 Points; US Mortgage Applications Decline

Benzinga
·
Oct 08, 2025

Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?

TIPRANKS
·
Oct 08, 2025

Top Premarket Gainers

MT Newswires Live
·
Oct 08, 2025

Xenetic Biosciences Q2 Net Income USD -700 Thousand

THOMSON REUTERS
·
Aug 13, 2025

Xenetic Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13, 2025

Xenetic Biosciences Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
Aug 09, 2025

Xenetic Biosciences Announces New Clinical Study Agreement with PeriNess to Advance DNase Platform for Large B Cell Lymphoma Treatment

Reuters
·
Jul 30, 2025

Xenetic Biosciences Expands Research Collaboration with Scripps Research to Advance DNase Platform for Lymphoma and Leukemia Models

Reuters
·
Jul 23, 2025

Xenetic Biosciences Announces Initiation of Exploratory Clinical Study on DNase I for Pancreatic Cancer Treatment in Israel

Reuters
·
Jul 08, 2025